Results 111 to 120 of about 23,691 (214)

Applications of Bioinorganic Nano‐Based Delivery Systems—Diagnostics and Therapeutics

Drug Development Research, Volume 87, Issue 5, August 2026.
ABSTRACT Nanotechnology has emerged as a promising avenue for producing nanomedicines as alternatives to conventional drugs. Many organic nanoparticles, such as liposomes used in formulations like Doxil, Onivyde, and Marqibo, are approved by the Food and Drug Administration (FDA) and instrumental in treating various types of cancers.
Frank Ssengooba, Jubilee Andrew, Donald Fernandes   +2 more
wiley   +1 more source

Timing of Carotid Blow‐Out After Locoregional Recurrence in Head and Neck Cancer: A Single‐Center Retrospective Study

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Background Carotid blow‐out syndrome (CBS) is a life‐threatening complication of head and neck cancer, often occurring after prior treatment and locoregional recurrence. Data on the timing of carotid rupture after local tissue compromise remain limited.
Fırat Tevetoğlu, Sinem Kara Peker, Chinara Aliyeva, Sevda Yener, Haydar Murat Yener   +4 more
wiley   +1 more source

Restriction‐Weighted Q‐Space Trajectory Imaging (ResQ): Toward Mapping Diffusion‐Time Effects With Tensor‐Valued Diffusion Encoding in Human Prostate Cancer Xenografts

NMR in Biomedicine, Volume 39, Issue 8, August 2026.
Tensor‐valued diffusion MRI enables microstructure characterization but can be confounded by the presence of restricted diffusion. We introduce ResQ, a framework that incorporates restriction weighting into q‐space trajectory imaging and we evaluate it in a longitudinal study of prostate cancer xenografts treated by external radiotherapy. ResQ revealed
Filip Szczepankiewicz, Malwina Molendowska, Samo Lasič, Marcella E. Safi, Michael Gottschalk, Evangelia Sereti, Anders Bjartell, Linda Knutsson, Oskar Vilhelmsson Timmermand, Crister Ceberg, Joanna Strand   +10 more
wiley   +1 more source

Prediction Models for Sentinel Lymph Node Metastasis in Clinically Node‐Negative Breast Cancer: Validation of Existing Nomograms, Model Development, and Ensemble Evaluation

World Journal of Surgery, Volume 50, Issue 8, Page 2219-2228, August 2026.
Prediction models using routine clinicopathological variables can identify patients with a very low risk of sentinel lymph node macrometastasis. Ensemble modeling modestly improves classification and increases the proportion of patients eligible for safe, risk‐adapted axillary de‐escalation.
Justin James, Kirti Mehta, Osamah Al‐Qershi, Emily Schembri, Michael Law, Shomik Sengupta, Christobel Saunders   +6 more
wiley   +1 more source

Breast Conserving Surgery and Sentinel Lymph Node Biopsy in Locally Advanced Breast Cancer: Single Center Experience

Balkan Medical Journal, 2011
Objective: Patients with locally advanced breast cancer may undergo breast conserving surgery after neoadjuvant chemotherapy. The aim of the study is to evaluate the results of locally advanced breast cancer patients who underwent breast conserving ...
Atakan Sezer, Ruşen Coşar Alas, İrfan Cicin, Zeki Hoşcoşkun, Nermin Tunçbilek   +4 more
doaj  

Efficacy of Adjuvant Interferon‐β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study

The Journal of Dermatology, Volume 53, Issue 8, Page 1124-1132, August 2026.
ABSTRACT Nail apparatus melanoma (NAM) is a biologically and clinically distinct subtype of melanoma; however, the efficacy of adjuvant interferon (IFN) therapy in this population remains unclear. We conducted a multicenter retrospective study to compare adjuvant IFN‐β (adj‐IFN) with observation (OBS) in patients with resected stage IIB, IIC, or III ...
Takaya Komori, Eiji Nakano, Yukiko Kiniwa, Shoichiro Mori, Sotaro Yamamoto, Hiroshi Kato, Shusuke Yoshikawa, Koji Yoshino, Megumi Aoki, Tatsuya Takenouchi, Takuya Maeda, Keijun Yoshino, Shuichi Ohe, Kenta Nakama, Hideyuki Ishikawa, Yoshiyuki Nakamura, Toshihiro Takai, Takamichi Ito, Hiroshi Kitagawa, Hiraku Kokubu, Naohito Hatta, Takeru Funakoshi, Toshihiko Hoashi, Takayuki Suyama, Susumu Fujiwara, Mamiko Masuzawa, Hiroshi Uchi, Takuya Miyagawa, Soichiro Kado, Yuki Yamamoto, Jun Asai, Junji Kato, Taku Maeda, Natsuki Baba, Yukihiko Kato, Kohei Oashi, Takeo Maekawa, Shunichi Jinnai, Aya Nishizawa, Ko Kagoyama, Atsushi Otsuka, Katsuhiko Nishihara, Dai Ogata, Kenjiro Namikawa, Yasuhiro Nakamura, Shigeto Matsushita   +45 more
wiley   +1 more source

Outcomes for Patients With Micro‐Invasive or Small HER2+ Breast Cancer in Northern Sydney Local Health District

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 4, Page 564-572, August 2026.
This retrospective study of patients with small, node‐negative HER2+ breast cancer found favorable 5‐year invasive disease‐free survival rates—93% for pT1mic/a disease and 100% for pT1b disease. Trastuzumab was administered to 66% of patients and was associated with larger tumor size and higher histologic grade.
Yuanyuan Xue, Katrina Moore, Tricia Saurine, David Chan, Lina Pugliano, Connie Diakos   +5 more
wiley   +1 more source

Sentinel Lymph Node Biopsy

Actas Dermo-Sifiliográficas (English Edition), 2019
openaire   +2 more sources

Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page 1052-1061, August 2026.
Summary Background and Objectives Complete lymph node dissection (CLND) is the standard of care in patients with regional nodal melanoma macrometastasis. However, evidence on surgical procedures in the era of adjuvant systemic therapies is lacking. Patients and Methods This retrospective multi‐center study included stage IIIB–D melanoma patients with ...
Kristine E. Mayer, Jessica C. Hassel, Jannik Sambale, Michael Erdmann, Mihaela‐Anca Sindrilaru, Julia Oberschmied, Alexander Thiem, Dirk Tomsitz, Jana Knuever, Max Schlaak, Carola Berking, Christian Posch, Tilo Biedermann, Oana‐Diana Persa   +13 more
wiley   +1 more source

Sentinel lymph node biopsy in vulvar cancer: current evidence, limitations, and future perspectives. [PDF]

J Gynecol Oncol
Bogani G, Obermair A, Testa A, Gargenese G, Chiappa V, Raspagliesi F, Hacker N.   +6 more
europepmc   +1 more source